Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a licensing agreement with South Korea-based LG Chem, a leading global chemical ...

LG Chem Hosts 'LG AI Bio Conference' with LG AI Research and U.S. Flagship Pioneering ...

View of LG Chem's Dasan plant. /Photo=LG Chem It has been confirmed that LG Chem has signed a definitive contract to sell its ...

LG Chem’s latest quarterly update on 14 August 2026 showed revenue of ₩14,175,901m and a move from a loss to a small profit, ...

LG Chem said Wednesday it aims to begin clinical development of a personalized mRNA cancer vaccine in 2029, leveraging ...

LG Chem leverages AI to target patients and drive personalized cancer vaccines in Korea AI-powered biomarker insights steer ...

A possible Solidigm IPO is raising concerns that SK Hynix's 3.5 million shareholders could face ownership dilution as SK ...

South Korea's LG Chem is expanding its use of artificial intelligence beyond drug candidate discovery into clinical trial patient selection ...

LG Chem held its first AI Bio Conference in Seoul, detailing personalized mRNA cancer vaccines and AI tools for precision ...

AVEO Oncology, an LG Chem company, (AVEO) announced today that an abstract was accepted for presentation at the upcoming 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain ...

The average one-year price target for Nan Ya Plastics (TWSE:1303) has been revised to NT$328.10 / share. This is an increase of 14.23% from the prior estimate of NT$287.23 dated September 29, 2026.

LG Chem is positioning AI as the central decision-making engine of its drug development operations, aiming to improve success ...